Speakers announced for this year’s International Pandemic Sciences Conference
17 April 2025
Meet the global experts set to present on the latest scientific advancements that will predict, identify and control future epidemic and pandemic threats.
Up to £16.5 million awarded to global consortium to overcome obstacles in infectious disease research
8 April 2025
The International Severe Acute Respiratory and emerging Infection Consortium (ISARIC) has been awarded up to £16.5 million to build on its globally-recognised efforts to prevent illness and deaths from epidemic-prone infectious diseases.
New science partnership to strengthen Africa’s pandemic resilience
27 March 2025
A groundbreaking research partnership is set to enhance Africa’s preparedness and response to future health crises.
RECOVERY trial team win NIHR Impact Prize
21 March 2025
Co-led by PSI Director Professor Sir Peter Horby, the RECOVERY trial was defined "one of the most well-known studies supported by the NIHR with clear national and global impact”.
Prioritising research to better address high-consequence outbreaks
19 March 2025
A new paper published in BMC Medicine analyses research prioritisation approaches for high-consequence pathogens.
New paper outlines ethical issues in clinical metagenomics
7 March 2025
This week, University of Oxford researchers published the first paper mapping clinical ethics questions raised by new metagenomic techniques for diagnosing disease in clinical practice.
Extended abstract deadline for International Pandemic Sciences Conference 2025
20 February 2025
The deadline for abstract submissions and bursary applications for the International Pandemic Sciences Conference 2025 has been extended to 23:59 GMT on Wednesday 26 February.
Advances in AI can help prepare the world for the next pandemic
19 February 2025
In the first study of this kind, PSI and Oxford researchers partner with global colleagues to outline how Artificial Intelligence can transform infectious disease research and save more lives.
New partnership to advance public health and life science research collaboration in West Africa
13 February 2025
PSI and Institut Pasteur de Dakar (IPD) will cooperate on developing vaccines and rapid diagnostics – as well as strengthening workforce in the vaccinology, clinical trials and biomanufacturing sectors.
Abstract submissions open for International Pandemic Sciences Conference 2025
6 February 2025
Abstract and bursary submissions are now open for the International Pandemic Sciences Conference 2025 – Getting Ahead of the Curve.
Pig research paves way for human respiratory vaccine development
9 January 2025
A study in pigs, which shows that inhaled vaccines could potentially reduce viral transmission and improve efficiency, is an important step toward advancing vaccines for human use.
Registration now open for International Pandemic Sciences Conference 2025
7 January 2025
Representatives from academia, industry, civil society, and the public sector are invited to register for the International Pandemic Sciences Conference 2025, taking place in Oxford and online from 30 June to 1 July 2025.
Optimising testing for disease surveillance with machine learning
19 December 2024
A new machine learning-informed strategy could support public health leaders to design better disease surveillance during a disease outbreak.
Nipah Virus Research Day showcases cross-disciplinary advances
6 December 2024
Over 100 researchers convened for a PSI-hosted event exploring the latest interdisciplinary research to combat this deadly virus.
University of Oxford unveils new vaccine development partnership
15 November 2024
Oxford Cancer, the Oxford Vaccine Group and the Pandemic Sciences Institute have announced a new collaboration with Belgian biotech innovator Univercells.
New study traces impact of COVID-19 pandemic on global movement and evolution of seasonal flu
11 November 2024
Increased genomic surveillance capacity allowed a deeper insight into the global distribution patterns of seasonal flu and other respiratory viruses.
Reconstructing a lifetime of flu infections to understand long-term trends
8 November 2024
Using antibody data and mathematical modelling, a new study estimates annual patterns of influenza infection and protection over the past fifty years.
£5.5m funding boost for health protection research on emerging and zoonotic infections
7 November 2024
University of Oxford collaborators from the Pandemic Sciences Institute and the Department of Statistics will keep contributing actively to the new iteration of the Health Protection Research Unit in Emerging and Zoonotic Infections.
Moh Family Foundation visit highlights vital support for pandemic preparedness research
24 October 2024
The Pandemic Sciences Institute welcomed the Moh Family Foundation to Oxford to share latest research updates and celebrate the Foundation’s generous support.
Large-scale study on Long Covid highlights urgent, global need for investment
22 October 2024
A new study in BMJ Global Health reveals the key Long Covid characteristics affecting populations worldwide, including fatigue, shortness of breath and having trouble thinking clearly. 6-12 months after hospital discharge, 70% of study participants were affected by Long Covid in high-income countries, and 42% in low and middle-income countries.